Inventor · disambiguated record
Martin Jack Borrok, Iii
Also filed as: BORROK II MARTIN · BORROK III MARTIN · BORROK III MARTIN J · BORROK III MARTIN JACK
7 granted patents·8 pending applications·15 citations·filing 2013–2024
79Inventor score
Top patents by PatentIndex Score
15 records- 0188US11608375B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2020·Granted Mar 21, 2023·2 cites·16 claims
- 0288US10829554B2Binding molecules specific for ASCT2 and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Nov 10, 2020·5 cites·20 claims
- 0387US11155606B2Antibody directed against S. aureus clumping factor a (ClfA)MEDIMMUNE LLC·Filed 2019·Granted Oct 26, 2021·3 cites·18 claims
- 0482US10011660B2Molecules with reduced effector function and extended half-lives, compositions, and uses thereofMEDIMMUNE LLC·Filed 2013·Granted Jul 3, 2018·5 cites·47 claims
- 0579US2024352098A1ANTIBODY DIRECTED AGAINST S. AUREUS CLUMPING FACTOR A (ClfA)MEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0676US2024124612A1Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 0773US11970527B2Antibody directed against S. aureus clumping factor A (ClfA)MEDIMMUNE LLC·Filed 2021·Granted Apr 30, 2024·0 cites·15 claims
- 0868US11767369B2Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2019·Granted Sep 26, 2023·0 cites·26 claims
- 0966US2025197511A1Methods for the treatment of thyroid eye diseaseHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 1061US2023406942A1Igf1r antibodiesHORIZON THERAPEUTICS IRELAND DAC·Filed 2023·Application pending·0 cites
- 1155US2023174651A1Materials and methods for hinge regions in functional exogenous receptorsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1251US2017267780A1Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1349US12134658B2Materials and methods for multidirectional biotransportation in virotherapeuticsJANSSEN BIOTECH INC·Filed 2021·Granted Nov 5, 2024·0 cites·18 claims
- 1449US2018258178A1Molecules with Reduced Effector Function and Extended Half-Lives, Compositions, and Uses ThereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 1543US2022112276A1Biosynthetic materials and methods for multidirectional biotransportationJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Jack Borrok, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →